| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Maintaining Pro Forma Adjusted Constant Currency Revenue Growth Guidance Range of 3.5% to 4.5% |
| 10 Sep 2026 |
Form 4: Salmon Sean, Director
Received 674 shares as a grant or award · Granted 4,444 Stock Option / (Right to Buy) |
| 10 Sep 2026 |
Form 3: Salmon Sean, Director
No securities owned |
| 09 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Wayne, Pa., September 8, 2026 - Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026. |
| 08 Sep 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 07 Aug 2026 |
8-K: Other Events
On August 7, 2026, Teleflex Incorporated (the “Company”) entered into an accelerated share repurchase program (the “ASR Transaction”) with Truist Bank (the “Counterparty”) to repurchase an aggregate of $250 million (the “Repurchase Price... |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Completes Sale of OEM Business and Will Deploy Net Proceeds to Reduce Debt and Repurchase Common Stock |
| 05 Aug 2026 |
8-K/A: Financial Statements and Exhibits
Teleflex Incorporated (referred to herein as the “Company” and “Teleflex") is a global provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural co... |
| 03 Aug 2026 |
8-K: Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure
Intends To Utilize Net Proceeds To Pay Down Debt and Repurchase Shares |
| 26 Jun 2026 | 11-K |
| 15 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
INDENTURE dated as of June 15, 2026 among Teleflex Incorporated, a Delaware corporation, (the “Company”) the Guarantors (as defined) and U.S. Bank Trust Company, National Association, a national banking association, as trustee. |
| 09 Jun 2026 |
Form 4: Randle Stuart A, Director
Gave up 4,054 shares to cover exercise price or tax ($526K) · Received 5,658 shares as a grant or award · Granted 2,192 Stock Option / (Right to Buy) |
| 09 Jun 2026 |
Form 4: Weidman Jason R., Director
Received 53,983 shares as a grant or award · Granted 26,071 Stock Option / (Right to Buy) |
| 09 Jun 2026 |
Form 3: Weidman Jason R., Director
No securities owned |
| 09 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On June 8, 2026, the independent members of the Board of Directors (the “Board”) of Teleflex Incorporated (the “Company”), upon recommendation by the Compensation Committee of the Board, approved a special restricted stock unit award wit... |
| 02 Jun 2026 |
8-K: Other Events
WAYNE, Pa. — June 1, 2026 – Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its private offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2032 (the “Notes”) at an issue price o... |
Loading...